Release Date: 30/04/24 08:19 Summary: Quarterly Activities/Appendix 5B Cash Flow Report Price Sensitive: Yes Download Document 1009.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%